WO2018082092A1 - Matériau de renforcement de tissu biologique - Google Patents

Matériau de renforcement de tissu biologique Download PDF

Info

Publication number
WO2018082092A1
WO2018082092A1 PCT/CN2016/104881 CN2016104881W WO2018082092A1 WO 2018082092 A1 WO2018082092 A1 WO 2018082092A1 CN 2016104881 W CN2016104881 W CN 2016104881W WO 2018082092 A1 WO2018082092 A1 WO 2018082092A1
Authority
WO
WIPO (PCT)
Prior art keywords
cellulose
biological tissue
reinforcing material
hydroxy groups
tissue
Prior art date
Application number
PCT/CN2016/104881
Other languages
English (en)
Inventor
Chiaki Tanaka
Yoshinari Yui
Shojiro Matsuda
Hideki TAKAMORI
Original Assignee
Gunze Limited
Gunze Medical Devices (Shenzhen) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunze Limited, Gunze Medical Devices (Shenzhen) Limited filed Critical Gunze Limited
Priority to JP2018567188A priority Critical patent/JP6678256B2/ja
Priority to CN201680090625.9A priority patent/CN109906091B/zh
Priority to PCT/CN2016/104881 priority patent/WO2018082092A1/fr
Publication of WO2018082092A1 publication Critical patent/WO2018082092A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/146—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Definitions

  • the present invention relates to a biological tissue-reinforcing material capable of more reliably reinforcing weakened tissue while preventing air leakage or fluid leakage without using fibrin glue, which is a blood product.
  • the most fundamental issue in the field of surgery is to repair a damaged or weakened organ or tissue. For example, bleeding of a damaged organ is still treated by stopping bleeding and suturing the wound, which is even now the most common surgical technique to treat bleeding.
  • Another important issue in the surgical treatment is to prevent fluid leakage or air leakage from weakened or damaged tissue. Particularly in the field of chest surgery, it is important to prevent air leakage due to pneumothorax or after resection of lung cancer.
  • pneumothorax is a disease that is difficult to treat because of the high recurrence rate unless properly treated.
  • Pneumothorax often occurs due to air leakage into a thoracic cavity from a stump or suture site of the lung after resection, a site of the lung after partial resection to remove lung cancer, or a damaged site of lung tissue due to injury; or air leakage intoathoraciccavityfromatearofcysts (called bullae) which are transformed from some alveoli.
  • Such leakage has been treated by pleurodesis in which lung tissue is allowed to adhere to pleura using drugs or through artificial chemical burns.
  • Pleurodesis can prevent recurrence of pneumothorax to some extent. However, if lung tissue does not tightly adhere to pleura, the recurrence rate increases. If further surgery is necessary, the adhesion between lung tissue and parietal pleura needs to be removed, which prolongs a surgical time or causes bleeding during removal of the adhesion. Therefore, new treatment alternative to pleurodesis has been sought.
  • pancreatic juice dissolves granulation tissue that is responsible for wound healing, and prevents the growth of the tissue, leading to difficulty in regeneration of pancreatic tissue. Furthermore, it is concerned that leaked pancreatic juice digests blood vessels to possibly cause postoperative hemorrhage, a life-threatening complication.
  • Non-Patent Literatures 1 to 4 suggest that this method reduces the recurrence rate of pneumothorax more than usual pleurodesis.
  • Non-Patent Literature 5 suggests that such a method is also used to prevent bleeding after liver resection in the field of digestive surgery.
  • Non-Patent Literature 1 J. Pediatric Surg, 42, 1225-1230 (2007)
  • Non-Patent Literature 2 Interact. Cardiovasc. Thorac. Surg, 6, 12-15 (2007)
  • Non-Patent Literature 3 The Journal of the Japanese
  • Non-Patent Literature 4 The Journal of the Japanese
  • Non-Patent Literature 5 The Japanese Journal of Clinical and Experimental Medicine, 84, 148 (2007)
  • the present invention is a biological tissue-reinforcing material including a laminated structure, the laminated structure including: a fiber structure, sponge body, or film made of a bioabsorbable polymer; and a film made of etherified cellulose that is produced through etherification of hydroxy groups of cellulose.
  • the present inventors have investigated the cause of air leakage or fluid leakage from a reinforced area of biological tissue having been reinforced using fibrin glue and a fiber structure or the like made of a bioabsorbable polymer in combination, and found that the problem occurs at an adhesion area attached with fibrin glue.
  • Fibrin glue which gels in a short time, is very useful as biological glue.
  • fibrin glue in the form of a gel is relatively hard, cohesive failure or interfacial peeling is likely to occur due to impact.
  • cohesive failure or interfacial peeling presumably occurs due to a very high pressure applied to lung tissue when the patient coughs or sneezes. Since gelled fibrin glue has almost no adhesion, once separated, it cannot adhere again. Air leakage or fluid leakage presumably occurs at such a separation area.
  • etherified cellulose that is produced through etherification of hydroxy groups of cellulose (hereinafter, also referred to as “etherified cellulose” ) than fibrin glue, and the use of such a film gives a biological tissue-reinforcing material causing no air leakage or fluid leakage. Accordingly, the inventors completed the present invention.
  • Etherified cellulose is a compound proven to be very safe, and gels in a short time like fibrin glue to act as glue to attach a fiber structure made of a bioabsorbable polymer to biological tissue.
  • a film made of etherified cellulose absorb moisture to gel, and very strongly adheres to biological tissue.
  • cohesive failure or interfacial peeling of the film can be prevented from occurring.
  • the film since such a film has a certain level of adhesion even after it gels, if cohesive failure or interfacial peeling occurs due to high pressure, the film can adhere again to prevent air leakage or fluid leakage.
  • a laminated structure prepared by stacking a film made of etherified cellulose on a fiber structure, sponge body, or film made of a bioabsorbable polymer can be used as a biological tissue-reinforcing material remarkably easy to use.
  • the biological tissue-reinforcing material of the present invention includes a laminated structure that includes a fiber structure, sponge body, or film made of a bioabsorbable polymer and a film made of etherified cellulose.
  • the fiber structure, sponge body, or film made of a bioabsorbable polymer is designed to exhibit a tissue-reinforcing effect, an air leakage prevention effect, and a fluid leakage prevention effect when it is attached to a damaged or weakened organ.
  • the film made of etherified cellulose absorbs moisture to gel, and acts as glue to attach the fiber structure or the like made of a bioabsorbable polymer to biological tissue.
  • the film made of etherified cellulose may be stacked on only one surface of the fiber structure, sponge body, or film made of a bioabsorbable polymer or may be stacked on both surfaces of the fiber structure, sponge body, or film made of a bioabsorbable polymer.
  • the biological tissue-reinforcing material in which the films made of etherified cellulose are stacked on the respective surfaces of the fiber structure, sponge body, or film made of a bioabsorbable polymer can very strongly adhere to biological tissue.
  • Non-limiting examples of the bioabsorbable polymer include synthetic absorbable polymers such as ⁇ -hydroxy acid polymers, for example, polyglycolide, polylactide (D, L, DL isomer) , glycolide-lactide (D, L, DL isomer) copolymers, glycolide- ⁇ -caprolactone copolymers, lactide (D, L, DL isomer) - ⁇ -caprolactone copolymers, poly (p-dioxanone) , or glycolide-lactide (D, L, DL isomer) - ⁇ -caprolactone copolymers; and natural absorbable polymers such as collagen, gelatin, chitosan, or chitin.
  • synthetic absorbable polymers such as ⁇ -hydroxy acid polymers, for example, polyglycolide, polylactide (D, L, DL isomer) , glycolide-lactide (D, L, DL isomer) copoly
  • a natural absorbable polymer may be used together therewith.
  • an ⁇ -hydroxy acid polymer which is a homopolymer or copolymer of at least one monomer selected from the group consisting of glycolide, lactide, ⁇ -caprolactone, dioxanone, and trimethylene carbonate is preferably used because of its high strength.
  • An ⁇ -hydroxy acid polymer which is a homopolymer or copolymer of a monomer containing glycolide is more preferably used because the polymer shows appropriate decomposition behavior.
  • the preferable lower limit of the weight average molecular weight of the polyglycolide is 30,000, and the preferable upper limit thereof is 1,000,000.
  • Polyglycolide having a weight average molecular weight of less than 30,000 is poor in strength and may not impart a sufficient tissue-reinforcing effect.
  • Polyglycolide having a weight average molecular weight of more than 1,000,000 slowly decomposes in the body and therefore may cause a foreign-body reaction.
  • the more preferable lower limit of the weight average molecular weight of the polyglycolide is 50,000, and the more preferable upper limit thereof is 300,000.
  • the fiber structure made of the bioabsorbable polymer may be in any form, including the form of a non-woven fabric, a knitted fabric, a woven fabric, gauze, or yarn, or a combination of these forms.
  • the form of a non-woven fabric is preferred.
  • the weight per unit area of the non-woven fabric is not particularly limited, and the preferable lower limit is 5 g/m 2 , and the preferable upper limit is 300 g/m 2 .
  • a non-woven fabric having a weight per unit area of less than 5 g/m 2 has strength not enough for a biological tissue-reinforcing material, and may not reinforce weakened tissue.
  • a non-woven fabric having a weight per unit area of more than 300 g/m 2 may result in poor adhesion to tissue.
  • the more preferable lower limit of the weight per unit area of the non-woven fabric is 10 g/m 2 , and the more preferable upper limit thereof is 100 g/m 2 .
  • the non-woven fabric may be produced by any method, and examples of the method include conventionally known methods such as electrospinning deposition, melt blowing, needle punching, spun bonding, flash spinning, hydroentanglement, air laying, thermal bonding, resin bonding, or wet processing.
  • the weight per unit area of the sponge body made of the bioabsorbable polymer is not particularly limited, and the preferable lower limit is 5 g/m 2 , and the preferable upper limit is 1,000 g/m 2 .
  • a sponge body having a weight per unit area of less than 5 g/m 2 has strength not enough for a biological tissue-reinforcing material, and may not reinforce weakened tissue.
  • a sponge body having a weight per unit area of more than 1,000 g/m 2 may result in poor adhesion to tissue.
  • the more preferable lower limit of the weight per unit area of the sponge body is 30 g/m 2 , and the more preferable upper limit thereof is 500 g/m 2 .
  • the thickness of the fiber structure or sponge body made of the bioabsorbable polymer is not particularly limited, and the preferable lower limit is 5 ⁇ m, and the preferable upper limit is 1 ⁇ m.
  • a fiber structure or sponge body made of the bioabsorbable polymer having a thickness of less than 5 ⁇ m is poor in strength and may not impart a sufficient tissue-reinforcing effect.
  • a fiber structure or sponge body made of the bioabsorbable polymer having a thickness of more than 1 mm may not sufficiently adhere to and fix tissue.
  • the more preferable lower limit of the thickness of the fiber structure or sponge body made of the bioabsorbable polymer is 10 ⁇ m, and the more preferable upper limit thereof is 0.5 mm.
  • the thickness of the film made of the bioabsorbable polymer is not particularly limited, and the preferable lower limit is 10 ⁇ m, and the preferable upper limit is 800 ⁇ m.
  • a film made of the bioabsorbable polymer having a thickness of less than 10 ⁇ m is poor in strength and may not impart a sufficient tissue-reinforcing effect.
  • a film made of the bioabsorbable polymer having a thickness of more than 800 ⁇ m may not sufficiently adhere to and fix tissue.
  • the more preferable lower limit of the thickness of the film made of the bioabsorbable polymer is 20 ⁇ m, and the more preferable upper limit thereof is 300 ⁇ m.
  • the fiber structure, sponge body, or film made of the bioabsorbable polymer may be subjected to hydrophilization.
  • the fiber structure subjected to hydrophilization rapidly absorbs moisture such as physiological saline upon contact, and is therefore readily handled.
  • Non-limiting examples of the hydrophilization include plasma treatment, glow discharge treatment, corona discharge treatment, ozone treatment, surface graft treatment, and ultraviolet irradiation treatment.
  • plasma treatment is preferred because this treatment markedly increases the water absorption rate without changing the outward appearance of the non-woven fabric.
  • the etherified cellulose is produced through etherification of hydroxy groups of cellulose.
  • hydroxyalkylated cellulose represented by the formula (1) below such as hydroxyethylated cellulose in which hydroxy groups of the cellulose have been replaced with hydroxyethyl groups or hydroxypropylated cellulose in which hydroxy groups of the cellulose have been replaced with hydroxypropyl groups; and carboxyalkylated cellulose such as carboxymethylated cellulose in which hydroxy groups of the cellulose have been replaced with carboxymethyl groups.
  • hydroxyethylated cellulose which is proven to be very safe, is preferred.
  • n represents an integer
  • R represents hydrogen or -R′OH in which R′represents an alkylene group.
  • the molar ratio of a diethylene glycol group to an ethylene glycol group is preferably 0.1 to 1.0, and the molar ratio of a triethylene glycol group to an ethylene glycol group (triethylene glycol group/ethylene glycol group) is preferably 0.1 to 0.5 in the hydroxyethylated cellulose.
  • the etherified cellulose having molar ratios within such ranges imparts excellent initial adhesion when the fiber structure, sponge body, or film made of the bioabsorbable polymer adheres to biological tissue through the film made of the etherified cellulose, and the high adhesion is maintained after adhesion. Even if cohesive failure or interfacial peeling occurs due to high pressure, the fiber structure, sponge body, or film can adhere again to prevent air leakage or fluid leakage.
  • the numbers of moles of ethylene glycol groups, diethylene glycol groups, and triethylene glycol groups can be measured, for example, by NMR or thermal decomposition GC-MS.
  • the preferable lower limit of the average number of molecules (molar substitution, MS) of alkylene oxides bonded to an anhydroglucose unit is 1.0, and the preferable upper limit thereof is 4.0.
  • the etherified cellulose having a MS within such a range can gel in a short time with high gel strength, and closely adhere to and fix tissue.
  • MS is less than 1.0, gelledhydroxyethylated cellulose tends to be less viscous.
  • the MS is more than 4.0, gelation tends to take a long time.
  • the more preferable lower limit of the MS is 1.3, and the more preferable upper limit thereof is 3.0.
  • the preferable lower limit of the average degree of substitution (DS) of alkylene oxides to hydroxy groups at positions 2, 3, and 6 of an anhydroglucose unit is 0.2, and the preferable upper limit thereof is 2.5.
  • the etherified cellulose having a DS within such a range can gel in a short time with high gel strength, and closely adhere to and fix tissue. When the DS is less than 0.2, gelationmay take a long time. When the DS is more than 2.5, the strength may decrease.
  • the more preferable lower limit of the DS is 0.3, and the more preferable upper limit thereof is 1.5.
  • the MS and DS can be calculated by determining the NMR spectrum of an aqueous solution of the hydroxyethylated cellulose, and measuring the intensities of signals belonging to carbon atoms of an anhydroglucose ring and carbon atoms of a substituent group in the spectrum (see, for example, JP H6-41926 B) .
  • 0.2 g of a sample, 30 mg of an enzyme (cellulase) , and an internal standard material are dissolved in 3 mL of heavy water.
  • the resulting solution is subjected to ultrasonication for 4 hours, and its NMR spectrum is determined using an NMR measuring device (e.g. JNM-ECX400P available from JEOL) under the conditions of the number of scanning of 700, pulse width of 45°, and observed frequency of 31,500 Hz.
  • an NMR measuring device e.g. JNM-ECX400P available from JEOL
  • the etherified cellulose may be cellulose that is produced through etherification and carboxylation of hydroxy groups of cellulose so that part of unetherified hydroxy groups are carboxylated (hereinafter, also referred to as “etherified and carboxylated cellulose” ) .
  • etherified and carboxylated cellulose enables strong adhesion to damaged sites with particularly large surface irregularities.
  • the etherified and carboxylated cellulose is produced through etherification and carboxylation of hydroxy groups of cellulose.
  • hydroxyalkylated and carboxylated cellulose such as hydroxyethylated and carboxylated cellulose in which hydroxy groups of the cellulose have been replaced with hydroxyethyl groups and carboxyl groups, or hydroxypropylated and carboxylated cellulose in which hydroxy groups of the cellulose have been replaced with hydroxypropyl groups and carboxyl groups.
  • Particularly preferred is hydroxyethylated and carboxylated cellulose because it is proven to be very safe.
  • hydroxyalkylated and carboxylated cellulose represented by the following formula (2) :
  • n represents an integer
  • R represents hydrogen or -R′OH in which R′ represents an alkylene group.
  • the molar ratio of a diethylene glycol group to an ethylene glycol group (diethylene glycol group/ethylene glycol group) in the hydroxyethylated and carboxylated cellulose is preferably 0.1 to 1.5, and the molar ratio of a triethylene glycol group to an ethylene glycol group (triethylene glycol group/ethylene glycol group) is preferably 0.1 to 1.0.
  • the lower limit of the average number of molecules (molar substitution, MS) of alkylene oxide bonded to an anhydroglucose unit is preferably 1.0, and the upper limit thereof is preferably 4.0.
  • the lower limit of the average degree of substitution (DS) of alkylene oxides to hydroxy groups at positions 2, 3, and 6 of an anhydroglucose unit is preferably 0.2, and the upper limit thereof is preferably 2.5.
  • the average number of molecules (MS) , the average degree of substitution (DS) , and the numbers of moles of ethylene glycol groups, diethyleneglycolgroups, andtriethyleneglycol groups in the hydroxyethylated and carboxylated cellulose can be measured, for example, byNMRor thermal decompositionGC-MS.
  • the hydroxyethylated cellulose can be produced, for example, by the reaction of an ethylene oxide with alkali cellulose produced by treating cellulose with an aqueous solution of an alkali.
  • alkali cellulose is produced from a fiber structure made of cellulose as a raw material by treating the fiber structure with an aqueous solution of an alkali such as sodium hydroxide. To the resulting alkali cellulose are added a certain amount of an ethylene oxide and a reaction solvent, and a reaction is performed.
  • an alkali such as sodium hydroxide
  • the etherified and carboxylated cellulose can be produced by, for example, carboxylating and then etherifying cellulose.
  • the cellulose may be carboxylated as follows, for example. Through a reaction with 2, 2, 6, 6-tetramethylpiperidine-l-oxyl (TEMPO) as an oxidant and sodium hypochlorite, hydroxy groups of the cellulose are oxidized to aldehyde (TEMPO oxidation step) . Subsequently, the cellulose is reacted with sodium chlorite so that the aldehyde is carboxylated (carboxylation step) .
  • TEMPO 2, 2, 6, 6-tetramethylpiperidine-l-oxyl
  • the resulting carboxylated cellulose is treated with an aqueous solution of an alkali such as sodium hydroxide (alkali treatment step) and is then reacted with ethylene oxide to be etherified (hydroxyethylated) (hydroxyethylation step) .
  • alkali treatment step an alkali such as sodium hydroxide
  • ethylene oxide ethylene oxide
  • etherified and carboxylated cellulose can be prepared.
  • carboxyl groups are mainly introduced to position 6 of cellulose, and hydroxyethyl groups are mainly introduced to position 2 or 6.
  • the preferable lower limit of the water absorption rate of the film made of the etherified cellulose is 200%, and the preferable upper limit thereof is 1,000%.
  • the film made of the etherified cellulose having a water absorption rate within such a range can gel in a short time with high gel strength, and closely adhere to and fix tissue.
  • gelation may take a long time.
  • gel strength tends to be iow.
  • the more preferable lower limit of the water absorption rate is 400%, and the more preferable upper limit thereof is 800%.
  • the water absorption rate herein can be measured by the following method.
  • the initial weight of a sample is measured, and the sample is placed in a petri dish. Distilled water is slowly dropped onto the sample.
  • the weight of the sample having absorbed distilled water to the maximum is determined as a maximum water absorption weight.
  • the water absorption rate can be calculated based on the following equation from the initial weight and the maximum water absorption weight.
  • Water absorption rate (%) (maximum water absorption weight-initial weight) /initial weight x 100
  • the preferable lower limit of the moisture absorption rate of the film made of the etherified cellulose is 7%, and the preferable upper limit thereof is 50%.
  • the fiber structure made of the etherified cellulose having a moisture absorption rate within such a range can gel in a short time with high gel strength, and closely adhere to and fix tissue. When the moisture absorption rate is lower than 7%, gelation may take a long time. When the moisture absorption rate is higher than 50%, the gel strength tends to be low.
  • the more preferable lower limit of the moisture absorption rate is 10%, and the more preferable upper limit thereof is 35%.
  • the moisture absorption rate used herein can be measured by the following method.
  • a sample is heated at 105°C for 2 hours.
  • the weight of the resulting sample is determined as an absolute dry weight.
  • the absolute dry sample is allowed to stand in an atmosphere at 20°C and 65%Rh for 7 hours to control the moisture content of the sample.
  • the weight of the sample is determined as a weight after moisture control.
  • a moisture absorption rate can be calculated based on the following equation from the absolute dry weight and the weight after moisture control.
  • Moisture absorption rate (%) (weight after moisture control-absolute dry weight) /absolute dry weight x 100
  • the thickness of the film made of the etherified cellulose is not particularly limited, and the preferable lower limit is 10 ⁇ m, and the preferable upper limit is 1,500 ⁇ m.
  • a film made of the etherified cellulose having a thickness of less than 10 ⁇ m may fail to attach the biological tissue-reinforcing material to biological tissue with sufficient adhesion.
  • Afilm made of the etherified cellulose having a thickness of more than 1,500 ⁇ m is less likely to absorb water, takes a long time to gel, and may not be readily handled.
  • the more preferable lower limit of the thickness of the film made of the etherified cellulose is 20 ⁇ m, and the more preferable upper limit thereof is 1,000 ⁇ m.
  • the fiber structure, sponge body, or film made of the bioabsorbable polymer and the film made of the etherified cellulose are preferably integrated to improve the handleability.
  • integrated herein means a state where two structures laminated to each other can be treated as one structure, and are not easily separated.
  • Non-limiting example of the mode of the integration include a mode in which a part of the fiber structure or sponge body made of the bioabsorbable polymer has entered a part of the film made of etherified cellulose.
  • the biological tissue-reinforcing material of the present invention is used to stop bleeding from a damaged or weakened organ or tissue, or to prevent air leakage or fluid leakage in the field of surgery.
  • the biological tissue-reinforcing material is favorably used to prevent air leakage due to pneumothorax or after resection of lung cancer in the field of chest surgery.
  • the biological tissue-reinforcing material of the present invention can be readily attached to an affected area just by applying the material preliminary immersed into physiological saline to the affected area. Furthermore, the biological tissue-reinforcing material absorbs blood or fluid from an affected area so that it can exhibit adhesion.
  • Fig. 1 is a view schematically illustrating a pressure tester used in the pressure test performed in examples.
  • the present invention can provide a biological tissue-reinforcing material capable of more reliably reinforcing weakened tissue while preventing air leakage or fluid leakage without using fibrin glue, which is a blood product.
  • a sol solution of hydroxyethylated cellulose was prepared by dissolving a commercial hydroxyethylated cellulose (available fromWako Pure Chemical Industries, Ltd., the molar ratio of a diethylene glycol group to an ethylene glycol group (diethylene glycol group/ethylene glycol group) : 1.06, the molar ratio of a triethylene glycol group to an ethylene glycol group (triethylene glycol group/ethylene glycol group) : 4.01) in distilled water so that the solution had a solid content of 7.5% by weight.
  • a commercial hydroxyethylated cellulose available fromWako Pure Chemical Industries, Ltd., the molar ratio of a diethylene glycol group to an ethylene glycol group (diethylene glycol group/ethylene glycol group) : 1.06, the molar ratio of a triethylene glycol group to an ethylene glycol group (triethylene glycol group/ethylene glycol group) : 4.01) in distilled water so that the solution had a solid content of 7.
  • a 150- ⁇ m-thick non-woven fabric made of polyglycolide was cut to have a length of 5.0 cm and a width of 5.0 cm to prepare a fiber structure made of a bioabsorbable polymer.
  • a small amount of a 70% ethanol solution was sprayed to one surface of the non-woven fabric made of polyglycolide using a spray to wet the surface of the non-woven fabric.
  • On the surface of the fabric made of polyglycolide was casted 6.8 g of the sol solution ofhydroxyethylatedcellulose. Air babbles formed after the casting were eliminated as much as possible by poking them with a needle wetted with ethanol.
  • the resulting fabric was dried at 60°C for two hours, thereby providing a biological tissue-reinforcing material including a laminated structure in which a film made of hydroxyethylated cellulose was stacked on one surface of the fabric made of polyglycolide.
  • the biological tissue-reinforcing material was punched into a 11-mm-diameter circular shape to give a test sample for measurement.
  • a pressure test was performed using a pressure tester 1 illustrated in Fig. 1.
  • a 150- ⁇ m-thick non-woven fabric made of polyglycolide was cut to have a length of 5.0 cm and a width of 5.0 cm to prepare a fiber structure made of a bioabsorbable polymer.
  • a small amount of a 70% ethanol solution was sprayed to one surface of the non-woven fabric made of polyglycolide using a spray to wet the surface of the non-woven fabric.
  • On the surface of the fabric made of polyglycolide was casted 3.4 g of a sol solution of hydroxyethylated cellulose prepared as in Example 1. Air babbles formed after the casting were eliminated as much as possible by poking them with a needle wetted with ethanol, followed by drying at 60°C for two hours.
  • abiological tissue-reinforcing material including a laminated structure in which films made of hydroxyethylated cellulose were stacked on the respective surfaces of the fabric made of polyglycolide was obtained.
  • the biological tissue-reinforcing material was subjected to a pressure test as in Example 1. Table 1 shows the result.
  • a sol solution of carboxymethylated cellulose was prepared by dissolving a commercial carboxymethylated cellulose (available fromWako Pure Chemical Industries, Ltd. ) in distilled water so that the solution had a solid content of 7.5% by weight.
  • a 150- ⁇ m-thick non-woven fabric made of polyglycolide was cut to have a length of 5.0 cm and a width of 5.0 cm to prepare a fiber structure made of a bioabsorbable polymer.
  • a small amount of a 70% ethanol solution was sprayed to one surface of the non-woven fabric made of polyglycolide using a spray to wet the surface of the non-woven fabric.
  • On the surface of the fabric made of polyglycolide was casted 3.4 g of the sol solution of carboxymethylated cellulose. Air babbles formed after the casting were eliminated as much as possible by poking them with a needle wetted with ethanol, followed by drying at 60°C for two hours.
  • the biological tissue-reinforcing material was subjected to a pressure test as in Example 1. Table 1 shows the result.
  • a 11-mm-diameter circular piece was punched out from a 150- ⁇ m-thick nonwoven fabric made of polyglycolide (NEOVEIL Type NV-M015G, GUNZE LIMITED) .
  • a collagen film was set on a filter holder of the pressure tester prepared in Example 1. Then, 20 ⁇ L of a solution A of fibrin glue (Beriplast P consisting of a solution A (mixture of fibrinogen powder and an aprotinin solution) and a solution B (mixture of thrombin powder and a calcium chloride solution) , available from CSL Behring K. K. ) was dropped onto the center of the collagen film in such a manner as to avoid the hole in the collagen film, and was spread into a shape with a diameter of approximately 11 mm. Next, the nonwoven fabric punched into a i1-mm-diameter circle was placed on the spread solution A and impregnated with the solution A. Subsequently, 20 ⁇ L of the solution A was dropped onto the nonwoven fabric, and the nonwoven fabric was sufficiently impregnated with the solution A. Thereafter, 20 ⁇ L of a solution B was dropped onto the nonwoven fabric.
  • fibrin glue Beriplast P consisting of a
  • a 150- ⁇ m-thick non-woven fabric made of polyglycolide was cut to have a length of 5.0 cm and a width of 5.0 cm to prepare a fiber structure made of a bioabsorbable polymer.
  • a 320- ⁇ m-thick fiber structure made of oxidized cellulose (available from Johnson &Johnson K. K., Surgicel) was cut to have a length of 5.0 cm and a width of 5.0 cm.
  • the fiber structure made of oxidized cellulose, the non-woven fabric made of polyglycolide, and the fiber structure made of oxidized cellulose were stacked in the stated order, and they were integrated by needle punching, thereby providing a biological tissue-reinforcing material.
  • the biological tissue-reinforcing material was subjected to a pressure test as in Example 1. Table 1 shows the result.
  • a sol solution of oxidized cellulose was prepared by dissolvingacommercialoxidizedcellulose (available fromWako Pure Chemical Industries, Ltd. ) in distilled water so that the solution had a solid content of 7.5% by weight.
  • a 150- ⁇ m-thick non-woven fabric made of polyglycolide was cut to have a length of 5.0 cm and a width of 5.0 cm to prepare a fiber structure made of a bioabsorbable polymer.
  • a small amount of a 70% ethanol solution was sprayed to one surface of the non-woven fabric made of polyglycolide using a spray to wet the surface of the non-woven fabric.
  • On the surface of the fabric made of polyglycolide was casted 3.4 g of the sol solution of oxidized cellulose. Air babbles formed after the casting were eliminated as much as possible by poking them with a needle wetted with ethanol, followed by drying at 60°C for two hours.
  • the biological tissue-reinforcing material was subjected to a pressure test as in Example 1. Table 1 shows the result.
  • the present invention provides a biological tissue-reinforcing material capable of more reliably reinforcing weakened tissue while preventing air leakage or fluid leakage without using fibrin glue, which is a blood product.

Abstract

L'invention concerne un matériau de renforcement de tissu biologique comprenant une structure stratifiée, la structure stratifiée comprenant : une structure fibreuse, un corps spongieux ou un film en un polymère bioabsorbable; et un film en cellulose éthérifiée qui est produite par éthérification de groupes hydroxy de cellulose. Le matériau de renforcement de tissu biologique peut renforcer de manière plus fiable un tissu affaibli tout en empêchant une fuite d'air ou une fuite de fluide sans utiliser de colle à la fibrine, qui est un produit sanguin.
PCT/CN2016/104881 2016-11-07 2016-11-07 Matériau de renforcement de tissu biologique WO2018082092A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2018567188A JP6678256B2 (ja) 2016-11-07 2016-11-07 生体組織補強材料
CN201680090625.9A CN109906091B (zh) 2016-11-07 2016-11-07 生物组织增强材料
PCT/CN2016/104881 WO2018082092A1 (fr) 2016-11-07 2016-11-07 Matériau de renforcement de tissu biologique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2016/104881 WO2018082092A1 (fr) 2016-11-07 2016-11-07 Matériau de renforcement de tissu biologique

Publications (1)

Publication Number Publication Date
WO2018082092A1 true WO2018082092A1 (fr) 2018-05-11

Family

ID=62075419

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/104881 WO2018082092A1 (fr) 2016-11-07 2016-11-07 Matériau de renforcement de tissu biologique

Country Status (3)

Country Link
JP (1) JP6678256B2 (fr)
CN (1) CN109906091B (fr)
WO (1) WO2018082092A1 (fr)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512122A1 (fr) * 1990-11-22 1992-11-11 Toray Industries, Inc. Materiau pour implants
CN1181979A (zh) * 1996-06-28 1998-05-20 庄臣及庄臣医药有限公司 防止手术后粘连的生物可消溶的氧化纤维素复合材料
US20060116696A1 (en) * 2003-04-17 2006-06-01 Odermatt Eric K Planar implant and surgical use thereof
CN101530353A (zh) * 2008-04-11 2009-09-16 北京天助畅运医疗技术有限公司 一种防粘连的疝修补片
CN101773689A (zh) * 2010-03-29 2010-07-14 苑国忠 外科修复补片
CN104874029A (zh) * 2015-03-30 2015-09-02 陕西佰傲再生医学有限公司 一种止血防粘连材料及其制备方法
CN104941011A (zh) * 2015-06-09 2015-09-30 烟台森森环保科技有限公司 一种用于医学手术中防止组织粘连的带细胞支架的医用膜
CN105963769A (zh) * 2016-06-16 2016-09-28 邢孟秋 医用卵清蛋白水凝胶粘合剂及其制备方法和用途

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512122A1 (fr) * 1990-11-22 1992-11-11 Toray Industries, Inc. Materiau pour implants
CN1181979A (zh) * 1996-06-28 1998-05-20 庄臣及庄臣医药有限公司 防止手术后粘连的生物可消溶的氧化纤维素复合材料
US20060116696A1 (en) * 2003-04-17 2006-06-01 Odermatt Eric K Planar implant and surgical use thereof
CN101530353A (zh) * 2008-04-11 2009-09-16 北京天助畅运医疗技术有限公司 一种防粘连的疝修补片
CN101773689A (zh) * 2010-03-29 2010-07-14 苑国忠 外科修复补片
CN104874029A (zh) * 2015-03-30 2015-09-02 陕西佰傲再生医学有限公司 一种止血防粘连材料及其制备方法
CN104941011A (zh) * 2015-06-09 2015-09-30 烟台森森环保科技有限公司 一种用于医学手术中防止组织粘连的带细胞支架的医用膜
CN105963769A (zh) * 2016-06-16 2016-09-28 邢孟秋 医用卵清蛋白水凝胶粘合剂及其制备方法和用途

Also Published As

Publication number Publication date
JP2019528806A (ja) 2019-10-17
JP6678256B2 (ja) 2020-04-08
CN109906091B (zh) 2021-10-15
CN109906091A (zh) 2019-06-18

Similar Documents

Publication Publication Date Title
Zhang et al. Oxidized cellulose-based hemostatic materials
RU2686466C2 (ru) Медицинское изделие и способ его изготовления
AU725479B2 (en) Bioabsorbable medical devices from oxidized polysaccharides
EP1718147B1 (fr) Agent hemostatique a usage topique et interne
JP5963130B2 (ja) 生体組織補強材料キット及び生体組織補強材料
TW200418529A (en) Hemostatic wound dressings and methods of making same
Cheng et al. Hydrogel-based biomaterials engineered from natural-derived polysaccharides and proteins for hemostasis and wound healing
CN103483625A (zh) 可吸收降解的多用途生物相容性材料
CN103418024A (zh) 一种新型可吸收医用材料
Atashgahi et al. Epinephrine-entrapped chitosan nanoparticles covered by gelatin nanofibers: A bi-layer nano-biomaterial for rapid hemostasis
US20100260845A1 (en) Biocompatible and Biodegradable Biopolymer Matrix
EP3284461A1 (fr) Agent hémostatique multifonctionnel et procédé de préparation associé
CN107530212B (zh) 生物组织加固材料
WO2018082092A1 (fr) Matériau de renforcement de tissu biologique
WO2017206131A1 (fr) Structure de fibre médicale et stratifié médical
CN103495211B (zh) 用于心脏手术的可吸收防粘连膜及其制备方法
CN111050812B (zh) 生物组织增强材料套件和生物组织增强材料
Matoba et al. Reduction of pulmonary air leaks with a combination of polyglycolic acid sheet and alginate gel in rats
CN111936175A (zh) 防粘连用组合物
JP6678255B2 (ja) 生体組織補強材料及び人工硬膜
RU2629841C1 (ru) Способ получения противоспаечного пленочного материала на основе карбоксиметилцеллюлозы
WO2023140088A1 (fr) Matériau de renforcement d'anastomose gastro-intestinale
RU2634577C1 (ru) Способ получения противоспаечного пленочного материала на основе производных целлюлозы
WO2000028978A1 (fr) Agents utiles pour reparer des sites tissulaires endommages

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16920768

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2018567188

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16920768

Country of ref document: EP

Kind code of ref document: A1